Not-For-Profit Hospital Corporation

Not-For-Profit Hospital Corporation was paid $62.16M by Medicaid between Jan 2018 and Dec 2024, across 279 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	183,262	$9.20M
2019	173,501	$9.42M
2020	135,309	$6.79M
2021	160,677	$9.35M
2022	129,804	$12.74M
2023	82,639	$9.08M
2024incomplete	43,182	$5.58M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	27%	72,430	64,791	$16.76M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	44,326	40,347	$8.95M
99282	Emergency department visit for the evaluation and management, low to moderate severity	9.5%	24,363	22,594	$5.89M
99281	Emergency department visit for the evaluation and management, self-limited or minor	5.9%	14,610	13,395	$3.66M
70450	Computed tomography, head or brain; without contrast material	5.4%	9,824	9,124	$3.36M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.7%	12,595	10,797	$2.89M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	3.1%	15,709	13,933	$1.95M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.0%	5,382	5,000	$1.88M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.5%	8,191	2,602	$1.56M
G0378	Hospital observation service, per hour	1.7%	13,009	5,376	$1.06M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.5%	10,984	7,767	$904K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.3%	2,476	2,338	$820K

267 more codes

71275	Computed tomographic angiography, chest, with contrast material	1.2%	1,580	$744K
99285	Emergency room visit (most serious)	1.0%	5,945	$628K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,333	$571K
97032		<1%	2,825	$569K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,287	$503K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,291	$498K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,904	$493K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,323	$415K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	3,865	$383K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,331	$367K
93971		<1%	2,348	$355K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	3,640	$337K
76830	Ultrasound, transvaginal	<1%	3,077	$310K
29581		<1%	1,241	$306K
99203	Doctor's office visit, new patient (routine)	<1%	1,413	$301K
76801		<1%	3,536	$293K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,348	$254K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,012	$248K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,610	$227K
71046	Radiologic examination, chest; 2 views	<1%	15,534	$225K
80053	Comprehensive metabolic panel	<1%	42,539	$206K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	414	$188K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	298	$175K
97162		<1%	927	$169K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	12,040	$167K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,309	$164K
76641		<1%	729	$148K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,211	$132K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,370	$122K
73562		<1%	3,679	$114K
80320		<1%	5,009	$113K
80048	Basic metabolic panel (calcium, ionized)	<1%	20,315	$109K
97163		<1%	677	$103K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	868	$101K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,489	$99K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	392	$96K
70486		<1%	1,914	$85K
73630		<1%	3,995	$80K
83880		<1%	8,715	$74K
76770		<1%	422	$71K
99215	Doctor's office visit, returning patient (complex)	<1%	403	$67K
87641		<1%	6,658	$62K
99204	Doctor's office visit, new patient (more involved)	<1%	345	$61K
73030		<1%	3,404	$61K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	99	$57K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	205	$56K
72110		<1%	1,095	$55K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,541	$54K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	28,624	$53K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	73	$49K
76937		<1%	1,302	$49K
93970		<1%	253	$46K
97165		<1%	310	$46K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	229	$45K
73130		<1%	4,188	$43K
73610		<1%	3,262	$42K
71250		<1%	526	$42K
84484		<1%	21,433	$40K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	53,216	$39K
70496		<1%	56	$34K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,372	$34K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	60	$33K
97116		<1%	400	$33K
97166		<1%	119	$33K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	149	$32K
71045	Radiologic examination, chest; single view	<1%	12,483	$31K
80047		<1%	3,942	$30K
87040		<1%	2,589	$29K
73502		<1%	1,366	$27K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	206	$26K
97161		<1%	94	$22K
73110		<1%	1,884	$22K
72100		<1%	889	$21K
84703		<1%	33,477	$21K
97535	Self-care/home management training, each 15 minutes	<1%	99	$20K
85378		<1%	3,623	$20K
84702		<1%	4,360	$19K
80329		<1%	961	$18K
83605		<1%	9,155	$18K
90715		<1%	670	$18K
86803		<1%	3,506	$16K
81001		<1%	40,773	$15K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	26	$14K
73564		<1%	1,532	$14K
87070		<1%	4,294	$13K
72131		<1%	148	$12K
86922		<1%	173	$11K
83735		<1%	16,325	$10K
97016		<1%	50	$10K
82947		<1%	19,887	$10K
76536		<1%	68	$10K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	42	$10K
36000		<1%	1,113	$10K
0011A		<1%	574	$9K
85027		<1%	5,908	$9K
76870		<1%	71	$9K
97012		<1%	37	$9K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	1,882	$8K
73080		<1%	772	$8K
77066	Tomosynthesis, mammo	<1%	94	$7K
93975		<1%	93	$7K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	11,282	$7K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,389	$7K
84443	Thyroid stimulating hormone (TSH)	<1%	3,420	$7K
88141		<1%	250	$7K
94060		<1%	212	$6K
72052		<1%	118	$6K
73590		<1%	860	$6K
87522	Neg quan hep c or qual rna	<1%	367	$6K
82552		<1%	4,531	$6K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	951	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,979	$5K
80076		<1%	1,842	$4K
99406		<1%	145	$4K
80061	Lipid panel	<1%	1,305	$4K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	132	$4K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	134	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	4,737	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,416	$4K
72040		<1%	107	$4K
83690		<1%	14,783	$4K
86850		<1%	4,269	$3K
73140		<1%	184	$3K
97597		<1%	38	$3K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	124	$3K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	26	$3K
72070		<1%	82	$3K
84436		<1%	3,214	$3K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,083	$3K
84100		<1%	6,120	$3K
70491		<1%	29	$2K
82962		<1%	2,185	$2K
87210		<1%	4,390	$2K
99386		<1%	13	$2K
82550		<1%	5,480	$2K
94010		<1%	102	$2K
85014		<1%	3,961	$2K
87186		<1%	2,879	$2K
73090		<1%	375	$2K
76642		<1%	14	$2K
36415	Collection of venous blood by venipuncture	<1%	917	$2K
76775		<1%	12	$2K
87275		<1%	6,192	$2K
85610		<1%	7,137	$2K
76942		<1%	108	$2K
90686		<1%	119	$2K
0004A		<1%	34	$2K
86901		<1%	4,261	$2K
73620		<1%	98	$1K
76000		<1%	481	$1K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	989	$1K
86900		<1%	4,263	$1K
73552		<1%	156	$1K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	2,273	$1K
74018		<1%	52	$983.42
87276		<1%	6,191	$936.47
87088		<1%	2,519	$935.65
85730		<1%	7,046	$928.21
94727		<1%	69	$849.12
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,527	$831.73
84479		<1%	3,175	$825.03
82803		<1%	844	$728.22
71101		<1%	200	$674.95
87077		<1%	2,241	$603.51
77065	Tomosynthesis, mammo	<1%	15	$583.71
86141		<1%	859	$561.15
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	41	$537.44
80050	General health panel	<1%	46	$520.32
73560		<1%	28	$489.11
82010		<1%	1,172	$437.69
97164		<1%	25	$431.59
36600		<1%	236	$413.62
85652		<1%	927	$348.52
72170		<1%	44	$344.71
74022		<1%	44	$323.73
80352		<1%	258	$317.80
80074		<1%	28	$311.90
G0432	Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening	<1%	44	$267.48
86592		<1%	151	$253.10
80185		<1%	27	$230.44
82728		<1%	100	$216.77
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	159	$210.05
87340		<1%	492	$203.57
87535		<1%	39	$199.16
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	749	$194.25
84550		<1%	76	$176.37
83718		<1%	13	$169.91
73521		<1%	12	$157.99
82553		<1%	65	$144.79
73060		<1%	70	$140.12
90472	Immunization administration, each additional vaccine (list separately)	<1%	68	$134.19
73660		<1%	12	$126.70
86703		<1%	167	$123.16
83520		<1%	174	$110.91
84153		<1%	35	$107.81
96375	Therapeutic injection; each additional sequential IV push	<1%	599	$103.36
80143		<1%	792	$101.36
88312		<1%	170	$98.74
84439		<1%	16	$96.15
82465		<1%	14	$80.50
82150		<1%	265	$76.66
J7120	Ringers lactate infusion, up to 1000 cc	<1%	806	$75.24
81003		<1%	429	$70.63
A4618	Breathing circuits	<1%	458	$61.54
G0008	Administration of influenza virus vaccine	<1%	73	$54.80
80179		<1%	753	$50.67
85044		<1%	96	$40.32
99001		<1%	179	$39.20
83550		<1%	43	$35.99
81025		<1%	287	$35.94
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	575	$29.92
81002		<1%	224	$29.87
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,495	$24.73
A7521	Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each	<1%	437	$21.08
84600		<1%	113	$11.64
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,432	$6.35
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,208	$6.07
J3490	Unclassified drugs	<1%	659	$5.95
94761		<1%	90	$5.87
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,180	$5.62
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	239	$2.72
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,618	$1.15
J2060	Injection, lorazepam, 2 mg	<1%	416	$0.48
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,165	$0.46
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	281	$0.23
C9113	Injection, pantoprazole sodium, per vial	<1%	216	$0.22
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	262	$0.04
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	252	$0.00
A6210	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	0%	503	$0.00
J1644	Injection, heparin sodium, per 1000 units	0%	914	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	468	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	291	$0.00
0272		0%	288	$0.00
A6457	Tubular dressing with or without elastic, any width, per linear yard	0%	1,095	$0.00
A6219	Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	0%	195	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	45	$0.00
A4730	Fistula cannulation set for hemodialysis, each	0%	61	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	53	$0.00
A6220	Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	0%	27	$0.00
94664		0%	72	$0.00
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	18	$0.00
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	0%	28	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	62	$0.00
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	0%	82	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	158	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	106	$0.00
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	0%	1,439	$0.00
96376		0%	68	$0.00
A6441	Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard	0%	252	$0.00
0270		0%	121	$0.00
99000		0%	101	$0.00
0250		0%	6,970	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	185	$0.00
J1815	Injection, insulin, per 5 units	0%	274	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	62	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	41	$0.00
J2704	Injection, propofol, 10 mg	0%	282	$0.00
0271		0%	63	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	14	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	77	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	257	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	26	$0.00
0258		0%	18	$0.00
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	14	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	20	$0.00
88304		0%	16	$0.00
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDIXON, MARLANNA (SPECIAL ASSISTANT TO THE CFO)